Salarius Pharmaceuticals, Inc. (SLRX) Stock Declining Despite No Negative News
Salarius Pharmaceuticals, Inc. (SLRX), a clinical-stage biotechnology company, has plunged 7.77% in the premarket trading session. As a result, SLRX stock is trading at $0.45 at the time of the writing. The slide has come despite a positive development for the company in the form of expansion in the oncology pipeline. On Thursday, the stock […]
Salarius Pharmaceuticals, Inc. (SLRX) Stock Declining Despite No Clear Reason
Salarius Pharmaceuticals, Inc. (SLRX), a clinical-stage biotechnology company, has declined by 1.76% in the premarket trading session. Consequently, SLRX stock s trading at $0.4793 at the time of the writing. On Thursday, SLRX closed the day at $0.49 after plunging 6.06% during the mid-day session. The last press release from the company was regarding a […]
